A detailed history of Primecap Management CO transactions in Galapagos Nv stock. As of the latest transaction made, Primecap Management CO holds 715,240 shares of GLPG stock, worth $19.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
715,240
Previous 678,877 5.36%
Holding current value
$19.1 Million
Previous $27.6 Million 16.55%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$32.2 - $42.44 $1.17 Million - $1.54 Million
36,363 Added 5.36%
715,240 $23 Million
Q4 2023

Feb 09, 2024

BUY
$31.87 - $40.71 $293,204 - $374,532
9,200 Added 1.37%
678,877 $27.6 Million
Q3 2023

Nov 13, 2023

BUY
$34.17 - $42.98 $112,761 - $141,834
3,300 Added 0.5%
669,677 $23.1 Million
Q2 2023

Aug 11, 2023

BUY
$37.4 - $44.52 $336,600 - $400,680
9,000 Added 1.37%
666,377 $27.1 Million
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $24 Million - $31.6 Million
657,377 New
657,377 $25.4 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.75B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.